Literature DB >> 32589444

Pressure overload generates a cardiac-specific profile of inflammatory mediators.

Matthew O'Brien1, Catalin F Baicu1, An O Van Laer1, Yuhua Zhang1, Lindsey T McDonald2,3, Amanda C LaRue2,3, Michael R Zile1,3, Amy D Bradshaw1,3.   

Abstract

Mechanisms that contribute to myocardial fibrosis, particularly in response to left ventricular pressure overload (LVPO), remain poorly defined. To test the hypothesis that a myocardial-specific profile of secreted factors is produced in response to PO, levels of 44 factors implicated in immune cell recruitment and function were assessed in a murine model of cardiac hypertrophy and compared with levels produced in a model of pulmonary fibrosis (PF). Mice subjected to PO were assessed at 1 and 4 wk. Protein from plasma, LV, lungs, and kidneys were analyzed by specific protein array analysis in parallel with protein from mice subjected to silica-instilled PF. Of the 44 factors assessed, 13 proteins were elevated in 1-wk PO myocardium, whereas 18 proteins were found increased in fibrotic lung. Eight of those increased in 1-wk LVPO were not found to be increased in fibrotic lungs (CCL-11, CCL-12, CCL-17, CCL-19, CCL-21, CCL-22, IL-16, and VEGF). Additionally, six factors were increased in plasma of 1-wk LVPO in the absence of increases in myocardial levels. In contrast, in mice with PF, no factors were found increased in plasma that were not elevated in lung tissue. Of those factors increased at 1 wk, only TIMP-1 remained elevated at 4 wk of LVPO. Immunohistochemistry of myocardial vasculature at 1 and 4 wk revealed similar amounts of total vasculature; however, evidence of activated endothelium was observed at 1 wk and, to a lesser extent, at 4 wk LVPO. In conclusion, PO myocardium generated a unique signature of cytokine expression versus that of fibrotic lung.NEW & NOTEWORTHY Myocardial fibrosis and the resultant increases in myocardial stiffness represent pivotal consequences of chronic pressure overload (PO). In this study, cytokine profiles produced in a murine model of cardiac fibrosis induced by PO were compared with those produced in response to silica-induced lung fibrosis. A unique profile of cardiac tissue-specific and plasma-derived factors generated in response to PO are reported.

Entities:  

Keywords:  cytokine; fibrosis; heart; inflammation; pressure overload; pulmonary

Mesh:

Substances:

Year:  2020        PMID: 32589444      PMCID: PMC7473927          DOI: 10.1152/ajpheart.00274.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  28 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction.

Authors:  Njabulo Ngwenyama; Ane M Salvador; Francisco Velázquez; Tania Nevers; Alexander Levy; Mark Aronovitz; Andrew D Luster; Gordon S Huggins; Pilar Alcaide
Journal:  JCI Insight       Date:  2019-04-04

Review 3.  Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.

Authors:  Carlo Agostini; Carmela Gurrieri
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 4.  Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.

Authors:  Nikolaos G Frangogiannis
Journal:  Mol Aspects Med       Date:  2018-08-02

Review 5.  T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Authors:  Robert M Blanton; Francisco J Carrillo-Salinas; Pilar Alcaide
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

6.  Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing.

Authors:  Kristine Y DeLeon-Pennell; Rugmani Padmanabhan Iyer; Osasere K Ero; Courtney A Cates; Elizabeth R Flynn; Presley L Cannon; Mira Jung; De'Aries Shannon; Michael R Garrett; William Buchanan; Michael E Hall; Yonggang Ma; Merry L Lindsey
Journal:  JCI Insight       Date:  2017-09-21

7.  The role of CCL12 in the recruitment of fibrocytes and lung fibrosis.

Authors:  Bethany B Moore; Lynne Murray; Anuk Das; Carol A Wilke; Amy B Herrygers; Galen B Toews
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

8.  Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release.

Authors:  Izabela Komarowska; David Coe; Guosu Wang; Robert Haas; Claudio Mauro; Madhav Kishore; Dianne Cooper; Suchita Nadkarni; Hongmei Fu; Daniel A Steinbruchel; Costantino Pitzalis; Graham Anderson; Pat Bucy; Giovanna Lombardi; Ross Breckenridge; Federica M Marelli-Berg
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

9.  Role of a novel immune modulating DDR2-expressing population in silica-induced pulmonary fibrosis.

Authors:  Lindsay T McDonald; Sara D Johnson; Dayvia L Russell; M Rita I Young; Amanda C LaRue
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

10.  Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

Authors:  Tania Nevers; Ane M Salvador; Francisco Velazquez; Njabulo Ngwenyama; Francisco J Carrillo-Salinas; Mark Aronovitz; Robert M Blanton; Pilar Alcaide
Journal:  J Exp Med       Date:  2017-10-02       Impact factor: 14.307

View more
  5 in total

1.  Mechanisms that limit regression of myocardial fibrosis following removal of left ventricular pressure overload.

Authors:  Lily S Neff; Yuhua Zhang; An O Van Laer; Catalin F Baicu; Mark Karavan; Michael R Zile; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-03       Impact factor: 5.125

Review 2.  New Progress in the Molecular Regulations and Therapeutic Applications in Cardiac Oxidative Damage Caused by Pressure Overload.

Authors:  Xiaomeng Shi; Arin Dorsey; Hongyu Qiu
Journal:  Antioxidants (Basel)       Date:  2022-04-29

Review 3.  From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.

Authors:  Walter J Paulus; Michael R Zile
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

4.  Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure.

Authors:  Sophie Nadaud; Mathilde Flamant; Wilfried Le Goff; Elise Balse; Catherine Pavoine
Journal:  Biomedicines       Date:  2022-01-20

Review 5.  Organized Chaos: Deciphering Immune Cell Heterogeneity's Role in Inflammation in the Heart.

Authors:  Alexa Corker; Lily S Neff; Philip Broughton; Amy D Bradshaw; Kristine Y DeLeon-Pennell
Journal:  Biomolecules       Date:  2021-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.